|
Routinely recommended laboratory tests for pregnant womena
|
Pregnant womena
|
Pregnant womenawith CMV-specific testingb
|
|---|
| |
# (%)
|
# (%)
|
|---|
|
Anemia testing
|
10,033 (13)
|
146 (1.5)
|
|
Glucose testing
|
54,989 (71)
|
1,228 (2.2)
|
|
Urine testing
|
54,947 (71)
|
1,311 (2.4)
|
|
Syphilis testing
|
65,047 (84)
|
1,613 (2.5)
|
|
Chlamydia testing
|
49,730 (64)
|
1,225 (2.5)
|
|
HIV testing
|
57,262 (74)
|
1,530 (2.7)
|
|
Hepatitis B testing
|
23,011 (30)
|
800 (3.5)
|
|
Rubella testing
|
15,546 (20)
|
650 (4.2)
|
- Note: CMV, cytomegalovirus; PCR, polymerase chain reaction; IgG, Immunoglobulin G; IgM, Immunoglobulin M; DFA, direct fluorescent testing; EIA, enzyme immunoassay.
-
aPregnant women defined as female enrollees who were 1) aged 15–44 years, 2) enrolled for the entire year in 2009, and 3) had a delivery code (defined in Appendix) between October-December 2009.
-
bCMV-specific testing includes CMV IgG, CMV IgM, CMV DFA, CMV EIA, and CMV PCR testing.
